# A Study of INO-A002 in Healthy Dengue Virus-naive Adults

> **NCT03831503** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** INO-A002
- **DEVICE:** CELLECTRA® 2000
- **DEVICE:** Dengue Fever Antibodies (IgG)

## Key facts

- **NCT ID:** NCT03831503
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-07
- **Primary completion:** 2022-10-03
- **Final completion:** 2022-10-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831503, "A Study of INO-A002 in Healthy Dengue Virus-naive Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03831503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*